Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Dermatology

Free Subscription 30.03.2026 1 Am J Dermatopathol 2 Am J Pathol 1 BMC Cancer 3 Br J Dermatol 1 Cancer Lett 9 Clin Exp Dermatol 8 Eur J Dermatol 3 Int J Dermatol 5 J Dermatol 1 J Invest Dermatol 1 Mycoses 1 N Engl J Med 5 Plast Reconstr Surg 1 PLoS Comput Biol 1 PLoS Genet 6 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. ZOU Y, Xia R, Li S, Li L, et al
   Accuracy of Confocal and Dermoscopic Criteria for Predicting Basal Cell Carcinoma Subtype.
   Am J Dermatopathol. 2026 Mar 23. doi: 10.1097/DAD.0000000000003136.
   PubMed         Abstract available
   
   

   
   Am J Pathol

2. FILGES S, Jonasson E, Arrabal MDCL, Andersson L, et al
   Single-cell triomics analysis of tumor cells infiltrating patient-derived breast cancer scaffolds.
   Am J Pathol. 2026 Jan 22:S0002-9440(26)00008.
   PubMed         Abstract available
   
   
3. ZHU R, Jiang G, Shen J, Gong C, et al
   Deciphering the cellular and metabolic landscape of lymph node metastasis in breast cancer using single-cell and spatial multi-omics.
   Am J Pathol. 2026 Jan 22:S0002-9440(26)00007.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. OKTEN IN, Baydas T, Koca S, Baltaci MF, et al
   Breast cancer surgery in the era of genetic uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance.
   BMC Cancer. 2026 Feb 13. doi: 10.1186/s12885-026-15721.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

5. HSU H, Yang CC, Huang SM, Wu MS, et al
   Topical Probiotics in Soybean Concentrate for Diabetic Foot Ulcers: A Randomised Controlled Trial.
   Br J Dermatol. 2026 Mar 27:ljag115. doi: 10.1093.
   PubMed        
   
   
6. RICAR J, Cetkovsky M, Cetkovska P
   Effective treatment of alopecia areata and psoriasis with baricitinib.
   Br J Dermatol. 2026 Mar 21:ljag106. doi: 10.1093.
   PubMed        
   
   
7. 
   Correction to: Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma: a nationwide population-based registry study from Sweden.
   Br J Dermatol. 2026 Mar 21:ljag096. doi: 10.1093.
   PubMed        
   
   

   
   Cancer Lett

8. WANG C, Sun J, Song J, Li S, et al
   Functional nanoplatforms overcoming immune resistance in skin cancers: Targeted immunomodulation, immunogenic cell death, and metabolic remodeling.
   Cancer Lett. 2026;647:218439.
   PubMed         Abstract available
   
   

   
   Clin Exp Dermatol

9. HJORT G, Schwarz CW, Bryld LE, Ajgeiy KK, et al
   Changes in Drug Survival of Adalimumab Over Time in Patients with Psoriasis - A Nationwide Cohort Study.
   Clin Exp Dermatol. 2026 Mar 25:llag142. doi: 10.1093.
   PubMed         Abstract available
   
   
10. VIDAL GONZALEZ A, Lopez Alcazar S, Escudero Tornero R, Vergara Barria FA, et al
    Upadacitinib in children under 12 years with dupilumab-refractory severe atopic dermatitis: a real-world case series.
    Clin Exp Dermatol. 2026 Mar 26:llag143. doi: 10.1093.
    PubMed         Abstract available
    
    
11. HALIOUA B, Demessant-Flavigny A, Merhand S, BenHayoun Y, et al
    Validation of the Dermatological Mental Load Questionnaire (DMLQ) in patients with chronic skin conditions.
    Clin Exp Dermatol. 2026 Mar 26:llag148. doi: 10.1093.
    PubMed        
    
    
12. CONLON O, Herlihy M, Harnett C
    Cost Differences Between Psoriasis Biologics: Implications for the Irish High Tech Scheme.
    Clin Exp Dermatol. 2026 Mar 26:llag145. doi: 10.1093.
    PubMed        
    
    
13. CHANG HC, Lo SW, Li YF, Chiu TM, et al
    Association between hidradenitis suppurativa and peripheral arterial occlusion disease: a propensity-score-matched cohort study.
    Clin Exp Dermatol. 2026;51:563-570.
    PubMed         Abstract available
    
    
14. MOLINELLI E, Gioacchini H, De Simoni E, Gambini D, et al
    Hidradenitis suppurativa associated with chromosomal abnormalities, genodermatoses and genetic disorders: a review.
    Clin Exp Dermatol. 2026;51:537-547.
    PubMed         Abstract available
    
    
15. CHEN YN, Shen CH, Tai CC, Wang TY, et al
    Adverse pregnancy outcomes among pregnant women with hidradenitis suppurativa: a systematic review and meta-analysis.
    Clin Exp Dermatol. 2026;51:578-586.
    PubMed         Abstract available
    
    
16. DEMIRBAS A, Diremsizoglu E, Esen M, Ulutas Demirbas G, et al
    Comparative effectiveness and safety of upadacitinib, abrocitinib and dupilumab in treatment-resistant prurigo nodularis.
    Clin Exp Dermatol. 2026;51:587-595.
    PubMed         Abstract available
    
    
17. KING STOKES N, McCusker S, Daly A, Hunjan M, et al
    Fraudulent responses in online survey research in dermatology: are your participants who you think they are?
    Clin Exp Dermatol. 2026;51:626-629.
    PubMed         Abstract available
    
    

    
    Eur J Dermatol

18. STARACE M, Alessandrini A, Bruni F, Barattini DF, et al
    Six-month open-label clinical study of a novel topical solution for mild distal lateral subungual onychomycosis.
    Eur J Dermatol. 2026;36:42-49.
    PubMed         Abstract available
    
    
19. PAGLIARELLO C, Girardelli CR
    Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.
    Eur J Dermatol. 2026;36:38-41.
    PubMed         Abstract available
    
    
20. ILINA N, Muller HH, Loffler H
    Skin physiology during daylight photodynamic therapy with additional fractional laser therapy.
    Eur J Dermatol. 2026;36:29-37.
    PubMed         Abstract available
    
    
21. FANTON GALLO B, Fogagnolo L, Avila Ferreira L, Cintra ML, et al
    Comparison between visual inspection, dermoscopy, and reflectance confocal microscopy in the diagnosis of lentigo maligna - a systematic review.
    Eur J Dermatol. 2026;36:3-12.
    PubMed         Abstract available
    
    
22. BERNARDO D, Azevedo A
    Granulomatous cutaneous disease associated with X-linked agammaglobulinaemia: a case report.
    Eur J Dermatol. 2026;36:80-82.
    PubMed        
    
    
23. GOLLER S, Briones LJ, Sanchez BR, Ferreira CS, et al
    Journal Club: Current state of neoadjuvant therapy for melanoma.
    Eur J Dermatol. 2026;36:76-80.
    PubMed        
    
    
24. KIM J, Pak K, Lee J, Shin K, et al
    Improvement of depressive symptoms in patients with severe atopic dermatitis treated with dupilumab: an open-label trial validated using the Beck depression inventory, Hamilton depression rating scale measures, and 18F-fluorodeoxyglucose positron emis
    Eur J Dermatol. 2026;36:73-75.
    PubMed        
    
    
25. SGOUROS D, Pappa G, Almpanis Z, Korogiannos A, et al
    Out of the blue: pulmonary metastasis from a melanoma arising in a blue nevus.
    Eur J Dermatol. 2026;36:63-65.
    PubMed        
    
    

    
    Int J Dermatol

26. PAOLINO G, Di Nicola MR, Ibba L, Narcisi A, et al
    Lebrikizumab After Multiple Prior Advanced Therapies in Moderate-To-Severe Atopic Dermatitis: A Real-World Case Series.
    Int J Dermatol. 2026 Mar 22. doi: 10.1111/ijd.70389.
    PubMed        
    
    
27. LITAIEM N, Nahali S, Slouma M, Mokni M, et al
    Prevalence and Risk Factors of Systemic Lupus Erythematosus in Patients With Chronic Cutaneous Lupus: A Bicentric Study Employing Three Classification Criteria.
    Int J Dermatol. 2026 Mar 25. doi: 10.1111/ijd.70399.
    PubMed         Abstract available
    
    
28. CHIRUMAMILLA V, Gallardo M, Korman AM, Fisher K, et al
    Radiology-Dermatology Diagnostic Variation in Skin and Soft Tissue Infections: A Cohort Analysis.
    Int J Dermatol. 2026 Mar 26. doi: 10.1111/ijd.70364.
    PubMed        
    
    

    
    J Dermatol

29. YAMADA R, Takamura S, Fukuda T
    Enfortumab Vedotin-Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity-Guided Management.
    J Dermatol. 2026 Mar 26. doi: 10.1111/1346-8138.70242.
    PubMed        
    
    
30. KATO M, Otsuka A, Dummer R
    Pediatric Skin Cancer: Melanoma, Basal and Squamous Cell Carcinomas, and Dermatofibrosarcoma Protuberans.
    J Dermatol. 2026 Mar 26. doi: 10.1111/1346-8138.70243.
    PubMed         Abstract available
    
    
31. OZAKI M, Hayama K, Fujita H
    Comparison of Severity Assessment Methods in Generalized Pustular Psoriasis: A Single-Center Study.
    J Dermatol. 2026 Mar 25. doi: 10.1111/1346-8138.70232.
    PubMed         Abstract available
    
    
32. OGURA Y, Honda T
    Serum Cytokine Dynamics in Dupilumab-Induced Psoriasiform Dermatitis: A Case Report.
    J Dermatol. 2026 Mar 25. doi: 10.1111/1346-8138.70237.
    PubMed        
    
    
33. GOTO M, Goto H, Bito T, Kawai R, et al
    Analysis of Medical Costs of Melanoma Using a Japanese National Database.
    J Dermatol. 2026 Mar 25. doi: 10.1111/1346-8138.70227.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

34. PONCE MB, Heaton AR, Burkard SK, D'Amato A, et al
    Atovaquone-induced therapeutic rewiring of melanoma metabolism.
    J Invest Dermatol. 2026 Mar 23:S0022-202X(26)00969.
    PubMed        
    
    

    
    Mycoses

35. VANAM HP, Ghazawi A, Aljneibi D, Khan M, et al
    The Evolving Landscape of Dermatophytosis in the UAE: Trichophyton indotineae and Related Genotypes.
    Mycoses. 2026;69:e70167.
    PubMed         Abstract available
    
    

    
    N Engl J Med

36. TOLANEY SM, Jiang Z, Zhang Q, Barroso-Sousa R, et al
    Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.
    N Engl J Med. 2025 Oct 29. doi: 10.1056/NEJMoa2508668.
    PubMed         Abstract available
    
    

    
    Plast Reconstr Surg

37. KIM M, Barnett JM, Olla DR, Lane WO, et al
    The Impact of Neoadjuvant Chemotherapy on Implant-Based Breast Reconstruction Outcomes.
    Plast Reconstr Surg. 2026;157:593-602.
    PubMed         Abstract available
    
    
38. PEREZ A, Schaverien MV, George-Palop M, Chang EI, et al
    The Impact of Vascularized Lymph Node Transfer in Reducing the Rate of Cellulitis in Breast Cancer-Related Lymphedema.
    Plast Reconstr Surg. 2026;157:463e-470e.
    PubMed         Abstract available
    
    
39. MA N, Li S, Liu C, Feng J, et al
    Oil Cysts after Fat Grafting Breast Augmentation May Be Avoided: A Clinical Evaluation of An Effective Fat Processing Technique.
    Plast Reconstr Surg. 2026;157:514e-521e.
    PubMed         Abstract available
    
    
40. ARYANPOUR Z, Cronin JE, Shah A, Yang JH, et al
    Perioperative Vitamin D Insufficiency Impacts Postoperative Outcomes in Abdominally Based Breast Reconstruction.
    Plast Reconstr Surg. 2026;157:605-611.
    PubMed         Abstract available
    
    
41. LAVA CX, Harish V, Li KR, Junn A, et al
    Residing in a Food Desert Is Associated with an Increased Risk of Complications after Breast Reconstruction.
    Plast Reconstr Surg. 2026;157:471e-479e.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

42. MORUNO-CUENCA A, Picart-Armada S, Bogle R, Fox J, et al
    singIST: An integrative method for comparative single-cell transcriptomics between disease models and humans.
    PLoS Comput Biol. 2026;22:e1014002.
    PubMed         Abstract available
    
    

    
    PLoS Genet

43. AARTS MT, Nordin A, Cantu C, van Boxtel AL, et al
    Mechanistic dissection of GRHL2 and PR transcriptional co-regulation in breast cells.
    PLoS Genet. 2026;22:e1012088.
    PubMed         Abstract available
    
    

    
    PLoS One

44. JENA M, Dehuri S, Cho SB
    SGA-DT: An adaptive fusion framework for missing data imputation and interpretable healthcare classification.
    PLoS One. 2026;21:e0343619.
    PubMed         Abstract available
    
    
45. DAY S, Harries J, Sawula B, Payne A, et al
    Navigating cancer: Insights from patient journey mapping.
    PLoS One. 2026;21:e0327113.
    PubMed         Abstract available
    
    
46. DE IORIO MG, Polli M, Ghilardi S, Frattini S, et al
    Prevalence and genotypic distribution of non-epidermolytic ichthyosis in Italian Golden Retrievers.
    PLoS One. 2026;21:e0345595.
    PubMed         Abstract available
    
    
47. AHMAD S, Qazi S, Bano N, Uddin R, et al
    Multitarget docking and molecular enumeration reveal DdpMPyPEPhU as a potent modulator of cell cycle, glucocorticoid, and estrogen signalling in breast cancer.
    PLoS One. 2026;21:e0344028.
    PubMed         Abstract available
    
    
48. NELSON MC, Rider LG, Kim H, Gillespie S, et al
    Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositis.
    PLoS One. 2026;21:e0343708.
    PubMed         Abstract available
    
    
49. ZHANG X, Gao Z, Miao Y, Wu XG, et al
    Association between cardiovascular disease and non-melanoma skin cancer: The mediation effect of obesity and inflammation.
    PLoS One. 2026;21:e0343992.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

50. CUI W, Xiao H, Wen X, Li C, et al
    Identifying a cancer therapeutic target: Cell-SELEX identifies a membrane protein for aptamer-mediated growth suppression.
    Proc Natl Acad Sci U S A. 2026;123:e2514681123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum